Access to the PPM Journal and newsletters is FREE for clinicians.

Meeting Highlights from American College of Rheumatology

Meeting Information

November 6-11, 2015
San Francisco, CA

More than 16,000 clinicians attended the ACR/ARHP Annual meeting. Over 450 educational sessions were held, designed to boost knowledge and provide the latest information in the field of rheumatology. To follow, is a summary of some of the advances in pain management presented during the meeting.

From this Meeting:

Repository corticotropin injection, a natural hormone product, may prove to have steroid-sparing properties in patients with active systemic lupus erythematosus.
Janus kinase (JAK-1) inhibitors are showing promised in the management of rheumatoid arthritis —targeting a source of out of control inflammation, cytokine signaling.
New biologic anifrolumab competes with belimumab as an alternative treatment of systemic lupus erythematosus.
Learn more about non-tumor necrosis factor for rheumatoid arthritis.
At the ACR meeting, a number of papers were presented that highlighted the human monoclonal antibody sarilumab, an emerging therapy for rheumatoid arthritis.
Tofacitinib shows promise as a treatment for ankylosing spondylitis.
close X